Select octogenarians with stage IIIa non–small cell lung cancer can benefit from trimodality therapyCentral MessagePerspective by Andrew Tang, MD, MS, Andrew Feczko, MD, Sudish C. Murthy, MD, PhD, Siva Raja, MD, PhD, Alejandro Bribriesco, MD, Dean Schraufnagel, MD, Usman Ahmad, MD, Daniel P. Raymond, MD, Monisha Sudarshan, MD, MPH

Get full text